Statin medication in patients with epiretinal membrane is associated with low intravitreal EPO, TGF-beta-1, and VEGF levels
Raimo Tuuminen,1 Sirpa Loukovaara2 1Department of Ophthalmology, Kymenlaakso Central Hospital, Kotka, Finland; 2Unit of Vitreoretinal Surgery, Dept of Ophthalmology, Helsinki University Hospital, University of Helsinki, Helsinki, FinlandBackground: In eyes with idiopathic epiretinal membrane (iERM),...
Guardado en:
Autores principales: | Tuuminen R, Loukovaara S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a582998d4220427abc009619eb1f62a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutations in <italic toggle="yes">hmg1</italic>, Challenging the Paradigm of Clinical Triazole Resistance in <named-content content-type="genus-species">Aspergillus fumigatus</named-content>
por: Jeffrey M. Rybak, et al.
Publicado: (2019) -
The value of pharmacogenetic markers for personalized approach to the statins treatment
por: N. V. Kokh, et al.
Publicado: (2013) -
Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy
por: Habte ML, et al.
Publicado: (2020) -
Refractive changes after lens-sparing vitrectomy for macular hole and epiretinal membrane
por: Muto T, et al.
Publicado: (2017) -
Muscle Response to the Association of Statin and Physical Exercise in Rats
por: Bonfim,Mariana Rotta, et al.
Publicado: (2009)